Scientists uncover promising treatment target for resistant brain cancer
For many patients with a deadly type of brain cancer called glioblastoma, chemotherapy resistance is a big problem.Credit: Clayton Metz/Virginia...
Rowan Blackwood covers cancer and oncology, including tumor biology, screening, diagnostics, treatment research, clinical trials, and survivorship science.
For many patients with a deadly type of brain cancer called glioblastoma, chemotherapy resistance is a big problem.Credit: Clayton Metz/Virginia...
In today's medical landscape, precision medicine and targeted therapies are gaining traction for their ability to tailor treatments to individual...
Researchers at Karolinska Institutet in Sweden have succeeded in delivering targeted cancer treatment via small membrane bubbles that our cells...
WASHINGTON, DC (May 20, 2024) — Gallbladder cancer rates have been stable or declining for most Americans over the last...
Washington (May 14, 2024) — Cancer-related studies, including a diagnostic tool for gastric cancer and trends in gallbladder and colorectal...
About The Study: This study found that BRCA1-associated protein (BAP1) tumor predisposition syndrome was associated with a high rate of nail...
“The advancement of novel therapies like CAR-T in relapsed and refractory pediatric B-ALL is truly a beacon of hope for...
A Cleveland Clinic-led team of scientists and physicians have discovered that the immune checkpoint protein VISTA can directly turn off...
A team of POSTECH and ImmunoBiome has made a significant breakthrough in the fight against cancer. Their research, published in...
(WASHINGTON, May 17, 2024) – People who use metformin are less likely to develop a myeloproliferative neoplasm (MPN) over time,...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine